Building on the success of its 6th edition, the 7th Vaccine World Asia Congress 2025 – South East Asia , emerges as the premier event for vaccine companies in the region. With the rising demand for vaccines to tackle diseases like dengue, hepatitis, and influenza, governments across Southeast Asia are prioritizing immunisation, driving significant investments in vaccine research, development, and distribution. Technological innovations, including mRNA vaccines and enhanced delivery systems, are revolutionizing the market, enabling more rapid and effective responses to health threats.
However, challenges such as logistical barriers, vaccine hesitancy, and economic disparities persist, especially in remote regions with limited healthcare infrastructure. Cold chain logistics and regulatory hurdles continue to hinder the efficient distribution of vaccines across the region.
7th Vaccine World Asia Congress 2025 – South East Asia stands as the go-to event for SEA vaccine companies, providing a platform to explore critical opportunities for growth. Key focuses will include expanding immunisation coverage in underserved areas, advancing universal vaccines, strengthening local manufacturing capabilities, accelerating research, improving manufacturing processes, and integrating innovative technologies to reshape vaccine development throughout Southeast Asia.
